Page last updated at 10:22 GMT, Thursday, 19 November 2009

NHS rejects new liver cancer drug


People with advanced liver cancer will be denied a new drug on the NHS under draft guidance published on Thursday.

The National Institute for Health and Clinical Excellence says the price of the drug is 'too high'. However, cancer charities have said it is the only drug that has been shown to extend patient's lives.

The new guidelines apply to England, Wales and Northern Ireland - Scotland have already rejected use of the drug.

Graham Satchell reports.


Story Tools


Sign in

BBC navigation

Copyright © 2019 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific